- cafead   Oct 21, 2022 at 10:22: AM
via Swiss pharma giant Roche has moved to strengthen its position in the KRAS-mutated cancer space through a $25 million licensing and collaboration agreement with Austrian arenaviral technology firm Hookipa Pharma.
article source
article source